Skip to content
healthcare.dev

OPDIVO

NDC 0003-3774, nivolumab, injection, from E.R. Squibb & Sons, L.L.C..

Product NDC
0003-3774
Status
Listed
Labeler
E.R. Squibb & Sons, L.L.C.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125554
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0003-3774 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NIVOLUMAB10 mg/mL

Pharmacologic classes

Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
0003-3774-12000033774121 VIAL, SINGLE-DOSE in 1 CARTON (0003-3774-12) / 10 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f570b9c4-6846-4de2-abfa-4d0a4ae4e394
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0003-3774

Use it

Look up 0003-3774 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0003-3774 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0003-3774. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.